Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
Tarsal tunnel release surgery has a 75–90% success rate when a specific compressive cause is identified on imaging — but only 50–65% success for idiopathic cases, and patients with both tarsal tunnel and plantar fasciitis respond better when both conditions are addressed simultaneously. Call (810) 206-1402 — tarsal tunnel evaluation in Michigan.
Tarsal tunnel release is a surgical procedure that decompresses the posterior tibial nerve and its branches by dividing the flexor retinaculum — the ligamentous roof of the tarsal tunnel on the medial ankle — along with any intrinsic compressive structures identified within the tunnel. The tarsal tunnel is a fibro-osseous canal running posterior and inferior to the medial malleolus, containing the posterior tibial nerve, tibial artery, tibial vein, and the tendons of the tibialis posterior, flexor digitorum longus, and flexor hallucis longus. Compression of the posterior tibial nerve within this tunnel produces tarsal tunnel syndrome: burning, tingling, and numbness along the medial heel, plantar arch, and toes in the distribution of the medial and lateral plantar nerves. Tarsal tunnel release is indicated when conservative management (custom orthotics, physical therapy, corticosteroid injection) has failed over 3-6 months, when nerve conduction studies confirm slowing across the tarsal tunnel, and when no alternative diagnosis explains the symptoms. The procedure is performed under local or regional anesthesia and requires careful decompression of all three nerve branches — the main posterior tibial nerve, the medial plantar nerve, and the lateral plantar nerve — including their distal portals of exit.
Tarsal Tunnel Release: Indications, Technique, and Outcomes
| Factor | Details |
|---|---|
| Indications for surgery | Failed conservative management (3-6 months minimum: orthotics, NSAIDs, PT, ≥1 corticosteroid injection); positive nerve conduction study (NCS) showing prolonged distal latency across tarsal tunnel; positive Tinel sign at tarsal tunnel; identifiable space-occupying lesion (ganglion, lipoma, varicosities, accessory muscle) on MRI; significant functional impairment; symptoms worse with activity and prolonged standing |
| Contraindications / poor candidates | Normal NCS without identifiable lesion (unpredictable outcomes); bilateral diffuse peripheral neuropathy (tarsal tunnel compression is often secondary finding); systemic inflammatory conditions not controlled; active local infection; morbid obesity without weight management; poorly controlled diabetes with diffuse neuropathy (decompression may not improve neuropathic symptoms) |
| Surgical technique | Medial incision posterior to medial malleolus (7-10 cm); identify and divide flexor retinaculum from proximal to distal; trace posterior tibial nerve distally; identify bifurcation into medial and lateral plantar nerves; decompress medial plantar nerve through abductor hallucis muscle fascia; decompress lateral plantar nerve through deep abductor hallucis fascia (the “knot of Henry” area); identify and excise any intrinsic compressive lesion; achieve meticulous hemostasis (perineural hematoma worsens outcome) |
| Space-occupying lesions found at surgery | Ganglion cyst (most common identifiable lesion — 25-30% of cases with positive MRI); lipoma; varicose veins/venous varicosities; accessory flexor digitorum longus muscle; post-traumatic fibrosis/scar; os trigonum compression; hypertrophied abductor hallucis; tenosynovitis of flexor tendons |
| Recovery | Splint and elevation 2 weeks; suture removal 14 days; protected weightbearing in surgical shoe 2-3 weeks; full weightbearing at 3-4 weeks; return to work (sedentary) 3-4 weeks; return to physical labor 6-8 weeks; neuropathic symptom improvement begins 3-6 weeks postoperatively and continues for up to 12 months as nerve heals |
| Outcomes | 60-90% good-to-excellent outcomes when clear compressive lesion identified; 40-70% when no lesion found but NCS positive; 20-40% when NCS normal (best avoided without confirmatory testing); symptom recurrence from scar formation around nerve 5-15% long-term; reoperation for scar neurolysis possible if symptoms recur after initial improvement |
Tarsal Tunnel Syndrome: Conservative vs. Surgical Management Decision Framework
| Factor | Favors Conservative Management | Favors Surgical Release |
|---|---|---|
| Duration of symptoms | <3 months; early presentation; symptoms improving | >6 months; plateau or worsening despite treatment |
| Nerve conduction study | Normal or equivocal NCS; symptoms bilateral (suggests systemic neuropathy) | Positive NCS with prolonged distal latency across tunnel; unilateral involvement |
| MRI findings | No space-occupying lesion; normal tunnel anatomy | Identifiable ganglion, lipoma, varicosities, or accessory muscle compressing nerve |
| Tinel sign | Negative or equivocal; diffuse distal neuropathy pattern | Strong positive Tinel at tarsal tunnel with radiation into plantar foot |
| Prior treatment | Not yet tried orthotics/PT/injection; recent new-onset | Failed 2+ conservative modalities including at least 1 injection; orthotic-refractory |
| Contributing factors | Systemic cause (diabetes, hypothyroidism) untreated; obesity; edema not addressed | Systemic causes addressed and optimized; isolated structural compression; flatfoot corrected or correctable simultaneously |
| Outcome predictors | Short symptom duration + normal NCS = poor surgical predictor | Positive NCS + positive Tinel + identifiable lesion + failed conservative = best surgical outcome predictors |
At Balance Foot & Ankle in Howell and Bloomfield Hills, tarsal tunnel syndrome workup includes nerve conduction studies and MRI of the tarsal tunnel before surgical planning — patients with positive electrodiagnostic studies and identifiable compressive lesions have the best outcomes from surgical release, and surgical decision-making includes simultaneous correction of any associated flatfoot deformity that contributes to tunnel compression. Call (810) 206-1402.
- High Arch Support: PowerStep supination insoles deliver firm, flexible high arch support plus a deep heel cradle for comfort, stability & motion control, helping align feet, reduce pain, and protect against ball & heel pressure.
- All Day Comfort & Support: PowerStep Pinnacle High shoe inserts for women and men use premium dual layer cushioning to deliver heel to toe comfort and responsive bounce back with every step, without going flat.
- Relieves & Helps Prevent Pain: PowerStep Pinnacle High insoles for supination can help alleviate common foot conditions often linked to supination, including plantar fasciitis, Achilles tendonitis, fat pad atrophy, and Morton’s neuroma.
- No Trimming: PowerStep insoles move easily from shoe to shoe. Inserts are sized by shoe size for footwear with removable factory insoles. Designed for walking, running, work & casual dress shoes; pairs well with best walking shoes for women and men.
- Made in the USA: We stand behind our PowerStep Insoles for women and men. Proudly made in the USA & backed by a 30-day money-back guarantee. HSA & FSA Eligible
OrthoInfo – AAOS: Tarsal Tunnel Syndrome
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Doctor Answer
What is a tarsal tunnel release and when is it indicated?
A tarsal tunnel release is a surgical decompression of the posterior tibial nerve and its branches as they pass through the tarsal tunnel on the inner ankle, indicated for tarsal tunnel syndrome that has failed at least 3 to 6 months of conservative treatment including orthotics and injections. The procedure involves releasing the flexor retinaculum to relieve nerve compression. Dr. Tom Biernacki at Balance Foot & Ankle performs tarsal tunnel release surgery with precise technique to decompress all nerve branches and provide lasting relief from burning heel and sole pain.
